A reminder – the cost per life saved of multiple C19 treatments

From here:

COVID-19 early treatment: real-time analysis of 4,216 studies (c19early.org)

“Treatment cost times the median NNT (number needed to treat) from studies reporting mortality results with calculable NNT. The numbers on the right are the number of mortality results and the corresponding improvement from meta analysis.

Costs are shown in $US and based on estimated costs for widespread distribution by governments.

Results reflect conditions as used in trials to date, these depend on the population treated, treatment delay, and treatment regimen. For example, vitamin C results are dominated by very late treatment studies with high control mortality.

Click the treatment name to see all studies, where the name of each study can be clicked on for the source paper. No treatment is 100% effective.

Protocols typically combine multiple treatments which may be complementary and synergistic. Treatment efficacy may vary by variant, especially for monoclonal antibodies. Only medications with ≥3 results are shown.

Cost per life saved may increase for variants with lower virulence. All treatments have potential side effects. All practical, effective, and safe means should be used based on risk/benefit analysis.

From here:

Ivermectin for COVID-19: real-time analysis of all 256 studies (c19ivm.org)

This analysis includes studies that were poorly designed or “designed to fail”.

There are a hyperlinks to each study on the website.

COVID-19 treatment cost effectiveness (c19early.org)

Onwards!!!

Please take a paid subscription or forward this article to those you think might be interested. You can also donate via Ko-fi – any amount from three dollars upwards. Ko-fi donations here:    https://ko-fi.com/peterhalligan